Concord Medical Services Holdings Ltd（CCM）股票分析

AI 分析 of Concord Medical Services Holdings Ltd (CCM)

買進

Concord Medical Services Holdings Ltd is a good buy right now due to its recent positive price momentum and improving financial metrics. The stock has increased by 3.92% over the last five days and has a forward P/E of 11.30, suggesting it may be undervalued compared to its earnings potential. Additionally, the gross margin has improved to 11.58%, indicating better operational efficiency. However, the main risk is the significant net loss of 32.8 million CNY in Q3 2025, which could impact future performance.

分析師評級（1）

賣出

0 買進

0 持有

1 賣出

目前: 3.71

最低

—

平均

—

最高

—

查看全部評級

估值指標

Concord Medical Services Holdings Ltd（CCM）目前預期本益比為 11.30，5 年平均預期本益比為 -31.33。

預期本益比

高估

5 年均值 P/E

-31.33

目前P/E

11.30

高估

-7.56

低估

-55.11

預期 EV/EBITDA

低估

5 年均值 EV/EBITDA

58.46

目前EV/EBITDA

0.00

高估

98.90

低估

18.03

預期股價營收比

低估

5 年均值 P/S

1.04

目前P/S

0.00

高估

1.59

低估

0.48

Alphio AI 對 CCM 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重（25 / 50 / 25），不構成保證。

樂

樂觀

樂觀 · 25%CCM

$5.00

情境價格

基

基準

基準 · 50%CCM

$4.82

情境價格

悲

悲觀

悲觀 · 25%CCM

$4.59

情境價格

CCM 常見問題 —— 由 Alphio AI 解答

Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector (OFFICES AND CLINICS OF DOCTORS OF MEDICINE industry).

Concord Medical Services Holdings Ltd is a good buy right now due to its recent positive price momentum and improving financial metrics. The stock has increased by 3.92% over the last five days and has a forward P/E of 11.30, suggesting it may be undervalued compared to its earnings potential. Additionally, the gross margin has improved to 11.58%, indicating better operational efficiency. However, the main risk is the significant net loss of 32.8 million CNY in Q3 2025, which could impact future performance.

1 analysts cover CCM: 0 rate it Buy, 0 Hold and 1 Sell.